{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T02:54:30Z","timestamp":1781405670939,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"NIGMS","doi-asserted-by":"publisher","award":["U24GM129547"],"award-info":[{"award-number":["U24GM129547"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R15HL135658"],"award-info":[{"award-number":["R15HL135658"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R44HL117511"],"award-info":[{"award-number":["R44HL117511"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["U54HL141981"],"award-info":[{"award-number":["U54HL141981"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["U54HL112309"],"award-info":[{"award-number":["U54HL112309"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R44HL110448"],"award-info":[{"award-number":["R44HL110448"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008043","name":"Palmerston North City Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006668","name":"Oregon Health and Science University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006668","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006206","name":"Biological and Environmental Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jtha.2024.05.024","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:01:23Z","timestamp":1717596083000},"page":"2449-2459","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain"],"prefix":"10.1016","volume":"22","author":[{"given":"Kenneth C.","family":"Childers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Cowper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan D.","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet R.","family":"McGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Davulcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pete","family":"Lollar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Doering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen H.","family":"Coxon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Paul C.","family":"Spiegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.05.024_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1532\/IJH97.05113","article-title":"Factor VIII structure and function","volume":"83","author":"Fay","year":"2006","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2024.05.024_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0021-9258(17)35234-1","article-title":"Sulfation of Tyr1680 of human blood coagulation factor VIII is essential for the interaction of factor VIII with von Willebrand factor","volume":"266","author":"Leyte","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.05.024_bib3","doi-asserted-by":"crossref","first-page":"21948","DOI":"10.1016\/S0021-9258(18)54729-3","article-title":"The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII","volume":"266","author":"Wise","year":"1991","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.05.024_bib4","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1073\/pnas.85.8.2429","article-title":"Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII)","volume":"85","author":"Pittman","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jtha.2024.05.024_bib5","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1538-7836.2004.00802.x","article-title":"Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX","volume":"2","author":"Lollar","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib6","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and a treatment of acquired hemophilia A","volume":"105","author":"Tiede","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.05.024_bib7","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1182\/blood-2016-02-701805","article-title":"High-affinity, noninhibitory pathogenic C1 domain antibodies are present in patients with hemophilia A and inhibitors","volume":"128","author":"Batsuli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.biocel.2011.03.014","article-title":"C1 domain residues Lys 2092 and Phe 2093 are of major importance for the endocytic uptake of coagulation factor VIII","volume":"43","author":"Meems","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jtha.2024.05.024_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaci.2011.08.029","article-title":"Uptake of blood coagulation factor VIII by dendritic cells is mediated via its C1 domain","volume":"129","author":"Herczenik","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jtha.2024.05.024_bib10","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood.2020008940","article-title":"Structure of blood coagulation factor VIII in complex with an anti\u2013C1 domain pathogenic antibody inhibitor","volume":"137","author":"Gish","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1182\/blood-2023-182304","article-title":"Structure of coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor","volume":"142","author":"Childers","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib12","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1182\/blood.V93.7.2267","article-title":"Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A","volume":"93","author":"Peerlinck","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib13","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0038-1649786","article-title":"Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin","volume":"74","author":"Santagostino","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/(SICI)1098-1004(1998)12:5<301::AID-HUMU2>3.0.CO;2-G","article-title":"Molecular diagnostics of 15 hemophilia a patients: characterization of eight novel mutations in the factor VIII gene, two of which result in exon skipping","volume":"12","author":"Tavassoli","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2024.05.024_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0037-1612984","article-title":"Non-inversion factor VIII mutations in 80 hemophilia A families including 24 with alloimmune responses","volume":"87","author":"Liu","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib16","first-page":"707","article-title":"The spectrum of mutations in Southern Spanish patients with hemophilia A and identification of 28 novel mutations","volume":"90","author":"Fern\u00e1ndez-L\u00f3pez","year":"2005","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2024.05.024_bib17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/ajh.23269","article-title":"Eradication of factor VIII inhibitors in patients with mild and moderate hemophilia A","volume":"87","author":"Kempton","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2024.05.024_bib18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1160\/TH12-07-0521","article-title":"Significance of F8 missense mutations with respect to inhibitor formation","volume":"109","author":"Schwaab","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib19","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/blood.V95.1.156","article-title":"A\u00a0human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor","volume":"95","author":"Jacquemin","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1182\/blood-2016-11-751347","article-title":"Frequency and epitope specificity of anti\u2013factor VIII C1 domain antibodies in acquired and congenital hemophilia A","volume":"130","author":"Kahle","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1538-7836.2006.01900.x","article-title":"Variable region heavy chain glycosylation determines the anticoagulant activity of a factor VIII antibody","volume":"4","author":"Jacquemin","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib22","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1182\/blood.V99.9.3235","article-title":"Antithrombotic effects of controlled inhibition of factor VIII with a partially inhibitory human monoclonal antibody in a murine vena cava thrombosis model","volume":"99","author":"Singh","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib23","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1538-7836.2004.00524.x","article-title":"Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice","volume":"2","author":"Dewerchin","year":"2004","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1538-7836.2008.03271.x","article-title":"A\u00a0human monoclonal antibody inhibiting partially factor VIII activity reduces thrombus growth in baboons","volume":"7","author":"Jacquemin","year":"2009","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib25","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.thromres.2011.06.027","article-title":"Partial versus complete factor VIII inhibition in a mouse model of venous thrombosis","volume":"129","author":"Emmerechts","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2024.05.024_bib26","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1089\/hum.2018.137","article-title":"Preclinical development of a hematopoietic stem and progenitor cell bioengineered factor VIII lentiviral vector gene therapy for hemophilia A","volume":"29","author":"Doering","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.jtha.2024.05.024_bib27","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/bjh.17227","article-title":"Characterisation and application of recombinant FVIII-neutralising antibodies from haemophilia A inhibitor patients","volume":"193","author":"Coxon","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.05.024_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"CryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.jtha.2024.05.024_bib29","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41592-020-00990-8","article-title":"Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction","volume":"17","author":"Punjani","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.jtha.2024.05.024_bib30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.V98.1.13","article-title":"Structure of a factor VIII C2 domain\u2013immunoglobulin G4kappa Fab complex: identification of an inhibitory antibody epitope on the surface of factor VIII","volume":"98","author":"Spiegel","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib31","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.jtha.2024.05.024_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1107\/S2059798318002425","article-title":"ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps","volume":"74","author":"Croll","year":"2018","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"10.1016\/j.jtha.2024.05.024_bib33","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1182\/blood-2007-08-109918","article-title":"The tertiary structure and domain organization of coagulation factor VIII","volume":"111","author":"Shen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib34","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.str.2008.03.001","article-title":"Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex","volume":"16","author":"Ngo","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.jtha.2024.05.024_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.14621","article-title":"The 3.2 \u00c5 structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain","volume":"18","author":"Smith","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib36","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2013-08-519124","article-title":"Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes","volume":"122","author":"Walter","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.697602","article-title":"Structure of blood coagulation factor VIII in complex with an anti-C2 domain non-classical, pathogenic antibody inhibitor","volume":"12","author":"Ronayne","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtha.2024.05.024_bib38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/jth.14668","article-title":"Unique surface-exposed hydrophobic residues in the C1 domain of factor VIII contribute to cofactor function and von Willebrand factor binding","volume":"18","author":"Przeradzka","year":"2020","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib39","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1182\/blood.2020009197","article-title":"Molecular determinants of the factor VIII\/von Willebrand factor complex revealed by BIVV001 cryo-electron microscopy","volume":"137","author":"Fuller","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib40","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1182\/blood-2009-01-197707","article-title":"Factor VIII C1 domain residues Lys 2092 and Phe 2093 contribute to membrane binding and cofactor activity","volume":"114","author":"Meems","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib41","doi-asserted-by":"crossref","first-page":"31289","DOI":"10.1074\/jbc.M113.497289","article-title":"Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa","volume":"288","author":"Wakabayashi","year":"2013","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.05.024_bib42","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1182\/blood.V104.11.1738.1738","article-title":"Antibody to C1 domain of factor VIII alters interaction of factor Xase complex with factor X","volume":"104","author":"Gilbert","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib43","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1111\/j.1538-7836.2005.01309.x","article-title":"Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII","volume":"3","author":"Jones","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.05.024_bib44","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The emerging importance of IgG Fab glycosylation in immunity","volume":"196","author":"van de Bovenkamp","year":"2016","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jtha.2024.05.024_bib45","doi-asserted-by":"crossref","first-page":"W526","DOI":"10.1093\/nar\/gkh468","article-title":"Protein structure prediction and analysis using the Robetta server","volume":"32","author":"Kim","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jtha.2024.05.024_bib46","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1182\/blood.2022015807","article-title":"Cryo-EM structure of the prothrombin-prothrombinase complex","volume":"139","author":"Ruben","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.05.024_bib47","doi-asserted-by":"crossref","first-page":"19049","DOI":"10.1074\/jbc.273.30.19049","article-title":"The A2 subunit of factor VIIIa modulates the active site of factor IXa","volume":"273","author":"Fay","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.05.024_bib48","doi-asserted-by":"crossref","first-page":"16302","DOI":"10.1074\/jbc.M011680200","article-title":"Factor IXa:factor VIIIa interaction. Helix 330-338 of factor IXa interacts with residues 558-565 and spatially adjacent regions of the A2 subunit of factor VIIIa","volume":"276","author":"Bajaj","year":"2001","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jtha.2024.05.024_bib49","doi-asserted-by":"crossref","first-page":"5094","DOI":"10.1021\/bi036289p","article-title":"Contribution of factor VIIIa A2 and A3-C1-C2 subunits to the affinity for factor IXa in factor Xase","volume":"43","author":"Jenkins","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2024.05.024_bib50","doi-asserted-by":"crossref","first-page":"32248","DOI":"10.1074\/jbc.M109.050781","article-title":"Identification of residues in the 558-loop of factor VIIIa A2 subunit that interact with factor IXa","volume":"284","author":"Jagannathan","year":"2009","journal-title":"J\u00a0Biol Chem"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624003155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:11:09Z","timestamp":1762549869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624003155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1538783624003155"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.024","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for inhibition of coagulation factor VIII reveals a shared antigenic hotspot on the C1 domain","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.05.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}